Bonn, Germany

Jasper Van Den Boorn

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Rheinische Friedrich-Wilhelms-Universitat Bonn. Active years: 2018-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jasper Van Den Boorn. Retrieved from https://idiyas.com/inventor/jasper-van-den-boorn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jasper Van Den Boorn: Innovator in Pharmaceutical Applications

Introduction

Jasper Van Den Boorn is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of pharmaceutical applications through his innovative work. With a total of 3 patents, he has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents, Jasper has developed RIG-I ligands and methods for producing them. This invention relates to new triphosphate-modified oligonucleotides that may act as RIG-I ligands. Additionally, he has created a new method that allows for the synthesis and purification of these ligands in high yield and purity, making them suitable for pharmaceutical applications.

Career Highlights

Jasper is affiliated with the Rheinische Friedrich-Wilhelms-Universität Bonn, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on the pharmaceutical industry.

Collaborations

He has collaborated with notable coworkers, including Marion Goldeck and János Ludwig, contributing to a dynamic research environment.

Conclusion

Jasper Van Den Boorn's contributions to the field of pharmaceutical applications through his innovative patents highlight his role as a leading inventor. His work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…